FindTrial
Sign In

A comparative study in nasotracheal fiberoptic intubation under conventional method v/s intravenous dexmedetomidine

A comparative study in nasotracheal fiberoptic intubation under conventional method v/s intravenous dexmedetomidine:prospective randomised study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017751
Enrollment
50
Registered
2019-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: dexmedetomidine iv 1 mcg/kg over 10 min,and spray as you technique with 2% lignocaine during fiberoptic bronchoscope insertion Intervention2: Fibre optic nasal intubati

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA I and ASA II . Patients undergoing GA with awake fiberoptic intubation in elective oropharyngeal , maxillo facial , mandibular surgeries , and general surgeries with difficult intubation.

Exclusion criteria

Exclusion criteria: head trauma, suspected base of skull fractures, nasal mass, allergy to local anaesthesia, pregnancy, infection at the local site

Design outcomes

Primary

MeasureTime frame
haemodynamic stability ( HR , SBP,DBP )Timepoint: 0,1,3,5,10,15,20 min—

Secondary

MeasureTime frame
vocal cord visibility, intubating conditions,duration of intubation, sedation using ramsay sedation score, patient comfort based on memory and recall.Timepoint: 0,1,3 min.—

Countries

India

Contacts

Public ContactDeepak Palanisamy

Institute of Medical Sciences, BHU

drrajaiims86@gmail.com9643975465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026